Pharma Meets AI Conference 2026: Key barriers to scaling AI in drug development
Strong systems that enable trust and governance are key to enabling the growth of AI technologies in drug development.
Artificial Intelligence
Eli Lilly and NVIDIA to build pharma’s “most powerful” supercomputer
Huawei’s three key steps to drive industrial intelligence forward and unleash AI’s full potential
First responders see AI and other advanced tech as essential
What does the EU Data Act mean for businesses?
Oxford University and Ellison Institute link for AI vaccine research
AI psychosis sees users ‘co-creating delusions with technology’ – expert
AI is improving idiopathic pulmonary fibrosis care
